Parr McKnight Wealth Management Group’s AbbVie ABBV Stock Holding History

Parr McKnight Wealth Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.95M	Sell	15,689 -427	-3%	-$91.9K	0.47%	67
2026 Q1	$3.51M	Sell	16,116 -10,690	-40%	-$2.37M	0.46%	69
2025 Q4	$6.12M	Sell	26,806 -1,477	-5%	-$336K	0.8%	34
2025 Q3	$6.55M	Sell	28,283 -439	-2%	-$89.4K	0.86%	27
2025 Q2	$5.33M	Sell	28,722 -7	-0%	-$1.3K	0.73%	36
2025 Q1	$6.02M	Sell	28,729 -413	-1%	-$80.3K	0.87%	26
2024 Q4	$5.18M	Buy	+29,142	New	+$5.36M	0.74%	33

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Parr McKnight Wealth Management Group's ABBV Position: Q2 2026 in Review

Parr McKnight Wealth Management Group reduced its AbbVie (ABBV) stake by 2.6% in Q2 2026, selling an estimated $91.9K and leaving 15,689 shares worth $3.95M. The position accounts for 0.47% of the portfolio, ranked #67.

Parr McKnight Wealth Management Group first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.55M in Q3 2025. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Parr McKnight Wealth Management Group held 15,689 shares of AbbVie worth $3.95M as of Q2 2026.
Parr McKnight Wealth Management Group sold 427 AbbVie shares in Q2 2026, an estimated $91.9K.
AbbVie made up 0.47% of Parr McKnight Wealth Management Group's portfolio in Q2 2026, its #67 holding.
Parr McKnight Wealth Management Group first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
Parr McKnight Wealth Management Group's AbbVie position peaked at $6.55M in Q3 2025.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Parr McKnight Wealth Management Group's 13F filing for Q2 2026, filed 5 Aug 2026.